Dapagliflozin Added to Glimepiride in Patients with Type 2 Diabetes Mellitus Sustains Glycemic Control and Weight Loss Over 48 Weeks: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial

  • Krzysztof Strojek
  • , Kun Ho Yoon
  • , Veronika Hruba
  • , Jennifer Sugg
  • , Anna Maria Langkilde
  • , Shamik Parikh

Research output: Contribution to journal › Article › peer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'Dapagliflozin Added to Glimepiride in Patients with Type 2 Diabetes Mellitus Sustains Glycemic Control and Weight Loss Over 48 Weeks: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science